News and publications

Validation agreement between the European Patent Organisation and Georgia

From January 15, 2024, inventors and businesses are able to validate in Georgia on the basis of the country’s national law their European patent applications and patents granted by the European Patent Office (EPO).

As a result, those European patent applications and patents validated in Georgia under the agreement will have the same effect and be subject to the same conditions as Georgia’s national patents.

The accompanying technical co-operation between the EPO and the National Intellectual Property Center of Georgia, SAKPATENTI, will bolster the development of Georgia’s national patent system and further foster innovation. The validation of European patents is also an important element for attracting foreign investment to Georgia.

The European Patent Organisation has 39 member states, including 27 member states of the European Union and 12 non-EU member states. Georgia will be the 5th country with the validation status and the 45th country where patent protection will be possible on the basis of a European patent application.

Under validation agreements, inventors and businesses are provided with a simple, timely and cost-efficient way of achieving high-level protection for an invention in the validation state, based on one single European patent application and without having to file a corresponding national patent application.

Validation for Georgia may be requested for any European patent or international (PCT) application filed on or after January 15, 2024.

pat

Recent Posts

Russia modernizes IP law for software-implemented inventions: greater clarity for digital technologies from 2027

Russia is updating its intellectual property legislation to reflect the way modern digital technologies are…

2 недели ago

Eurasian Patent Term Extensions: Patentica’s Guide in The Patent Lawyer Magazine

Patentica is proud to announce that our Eurasian patent attorneys, Ekaterina Petrova and Victor Lisovenko,…

1 месяц ago

Pharmaceutical innovation in Eurasia: AstraZeneca registers a new medicine in Russia

AstraZeneca has registered Baxfendi (baxdrostat) in Russia for the treatment of arterial hypertension. The medicine…

1 месяц ago

EAPO joins the Hague System: what will change for applicants from October 10, 2026

On July 10, 2026, the Eurasian Patent Organization (EAPO) acceded to the Geneva Act of…

2 месяца ago

Russia and Indonesia strengthen cooperation in intellectual property

Rospatent and Indonesia's Ministry of Law have signed a Memorandum of Understanding (MoU) to expand…

3 месяца ago

Five years of the Eurasian system for the protection of industrial designs

In 2026, the Eurasian industrial design system marks its fifth anniversary. Over the past five…

5 месяцев ago